Amivantamab in EGFR Exon 20 Insertion–Mutated NSCLC Progressing on Platinum Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
J. Clin. Oncol 2021 Aug 02;[EPub Ahead of Print], K Park, EB Haura, NB Leighl, P Mitchell, CA Shu, N Girard, S Viteri, JY Han, SW Kim, CK Lee, JK Sabari, AI Spira, TY Yang, DW Kim, KH Lee, RE Sanborn, J Trigo, K Goto, JS Lee, JC Yang, R Govindan, JM Bauml, P Garrido, MG Krebs, KL Reckamp, J Xie, JC Curtin, N Haddish-Berhane, A Roshak, D Millington, P Lorenzini, M Thayu, RE Knoblauch, BC ChoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.